Bénézit, François
Loubet, Paul
Galtier, Florence
Pronier, Charlotte
Lenzi, Nezha
Lesieur, Zineb
Jouneau, Stéphane
Lagathu, Gisèle
L’Honneur, Anne-Sophie
Foulongne, Vincent
Vallejo, Christine
Alain, Sophie
Duval, Xavier
Houhou, Nawal
Costa, Yolande
Vanhems, Philippe
Amour, Sélilah
Carrat, Fabrice
Lina, Bruno
Launay, Odile
Tattevin, Pierre https://orcid.org/0000-0003-3617-5411
,
Loulergue, P.
Momcilovic, S.
Mira, J. P.
Marin, N.
Regent, A.
Kanaan,
Dumas, F.
Doumenc, B.
Alexandra, J. F.
Becheur, H.
Belghalem, K.
Bernard, J.
Bleitreu, A.
Boisseau, M.
Bories, R.
Brugiere, O.
Brunet, F.
Burdet, C.
Casalino, E.
Caseris, M.
Chansiaux,
Chauchard, M.
Chavance, P.
Choquet, C.
Cloppet-Fontaine,
Colosi, L.
Couset, B.
Crestani, B.
Crocket, F.
Debit, A.
Delanoe,
Descamps, V.
Dieude, P.
Dossier, A.
Douron, N.
Dupeyrat, E.
Emeyrat, N.
Fernet,
Goulenok, T.
Harent, S.
Jouenne,
Justet, A.
Lachatre, M.
Leleu, A.
Lerat, I.
Lilamand, M.
Mal, H.
Marceau, A.
Metivier, A.-C.
Oplelatora, K.
Papo, T.
Pelletier, A.-L.
Pereira, L.
Pradere, P.
Prommier,
Ralainnazava, P.
Ranaivoision, M.
Raynaud-Simon, A.
Rioux, C.
Sacre, K.
Verry, V.
Vuong, V.
Yazdapanah, Y.
Géraud, P.
Driss, V.
Maugueret, V.
Ray, M.
Letois, F.
Mura, T.
Merle, C.
Bourdin, A.
Konaté, A.
Capdevilla, X.
Du Cailar, G.
Terminet, A.
Blain, H.
Leglise, M.-S.
Le Quellec, A.
Corne, P.
Landreau, L.
Klouche, K.
Bourgeois, A.
Sebbane, M.
Mourad, G.
Leray, H.
Maarouf, M.
Postil, D.
Alcolea, S.
Couve Deacon, E.
Rogez, S.
Argaud, L.
Tazarourte, K.
Hernu, R.
Cour, M.
Simon, M.
Baudry, T.
Jacquin, L.
Lainé, F.
Laviolle, B.
Allain, J.-S.
Belhomme, N.
Thibault, V.
Rochas, S.
Cochennec, S.
Ouamara-Digue, E.
Lepape, C.
Revest, M.
Simon, S.
Fouchard, J.
Gautier, C.
Nouredine, N.
Thébault, E.
Article History
Received: 13 August 2019
Accepted: 24 December 2019
First Online: 13 February 2020
Compliance with ethical standards
:
: The authors declare no competing interest related to the study. O Launay is an investigator for clinical trials sponsored by Janssen and other companies and received travel support to attend scientific meetings from pharmaceutical companies.